55
https://pubmed.ncbi.nlm.nih.gov/38093131
Expression levels of miR-181а and miR-25 in serum can serve as potential indicators for malignant transformation risk in certain patients with benign breast diseases and reflect different pathological processes within tumors in patients with invasive carcinoma of no specific type.
